X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CBIO

Closed

Catalyst Biosciences Inc

16.15
+0.01 (+0.06%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 16.14
Day's Range: 16.06 - 16.735
Send
When Written:
 
0.207
Catalyst Biosciences Inc is a clinical-stage biopharmaceutical company that develops novel medicines to address serious medical conditions. The company's focus is on the development of proteases, enzymes that play a critical role in physiological processes, and the development of small molecule drugs that target proteases. Catalyst Biosciences is headquartered in South San Francisco, California, and was founded in 2002. The company's pipeline includes potential treatments for hemophilia, complement-mediated diseases, and other rare bleeding disorders. Catalyst Biosciences has partnerships with several pharmaceutical companies, including Pfizer and Biogen. The company is publicly traded on the NASDAQ stock exchange under the ticker symbol CBIO.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X